MoneyWorks4Me

Indoco Remedies informs about disclosure

03 Dec 2024 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024, Indoco Remedies has informed that it enclosed Annexure A the details of the Show Cause Notice (SCN) u/s 73(1) in Form GST DRC – 01 received from the Goods and Service Tax (GST) Authority. Based on the advice of its advisors, Company will be filing appropriate response to the said Notice within the prescribed timelines.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..